Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found.
respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found.
"Traditionally, CAR-T cells have been administered by expert teams at university-based medical centers, which of course limits access to this very-needed therapy," said lead researcher Dr. Yuliya Linhares, chief of lymphomaResearchers said patients and caregivers must often travel to centers far from home for CAR-T treatment and secure temporary housing. Because they must be closely monitored, they are advised to stay within one hour of the treatment center.
Ultimately, 70% of study participants received the therapy on an outpatient basis. Of those, a quarter were never hospitalized. Of those who did go to the hospital, six days was the median stay for those treated on an outpatient basis, meaning half had shorter stays, half had longer ones. Those who received CAR-T cells as inpatients had a 15-day stay.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CAR-T Therapy Won't Raise Odds for a Second CancerContrary to a warning placed on labels for CART-T cancer therapies, use of these treatments does not appear to boost the odds for a secondary cancer later, a new study shows.
Read more »
Novel bone cancer therapy has 99% success rate, tests showBioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer.
Read more »
Meet Ardi: therapy dog bringing comfort to cancer patients in UtahAt the Huntsman Cancer Institute, Ardi, a 5-year-old Great Pyrenees, is more than just a dog — he’s a source of comfort and support for cancer patients.
Read more »
BMI's relation to cancer therapy mortality risks not so straightforwardResearchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not be the optimal treatment for obese patients.
Read more »
Hospitals begin offering breakthrough radiation therapy for metastatic cancer tumorsRadiation is part of treatment for about half of cancer patients. A breakthrough could change the future of the treatment.
Read more »
Using a molecular scissors to improve CAR-T cell therapyResearchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate antibodies and gene editing to improve the outcome of this breakthrough treatment for patients.
Read more »